143 related articles for article (PubMed ID: 37898347)
21. White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice.
Sakane S; Hikita H; Shirai K; Myojin Y; Sasaki Y; Kudo S; Fukumoto K; Mizutani N; Tahata Y; Makino Y; Yamada R; Kodama T; Sakamori R; Tatsumi T; Takehara T
Cell Mol Gastroenterol Hepatol; 2021; 12(5):1683-1699. PubMed ID: 34303881
[TBL] [Abstract][Full Text] [Related]
22. Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?
Cordeiro A; Costa R; Andrade N; Silva C; Canabrava N; Pena MJ; Rodrigues I; Andrade S; Ramalho A
Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):394-402. PubMed ID: 32044284
[TBL] [Abstract][Full Text] [Related]
23. Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels.
Zhu W; Liang A; Shi P; Yuan S; Zhu Y; Fu J; Zheng T; Wen Z; Wu X
BMC Gastroenterol; 2022 Apr; 22(1):196. PubMed ID: 35448944
[TBL] [Abstract][Full Text] [Related]
24. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
[TBL] [Abstract][Full Text] [Related]
25. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Zhang X; Ji X; Wang Q; Li JZ
Protein Cell; 2018 Feb; 9(2):164-177. PubMed ID: 28643267
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.
Lim S; Taskinen MR; Borén J
Obes Rev; 2019 Apr; 20(4):599-611. PubMed ID: 30589487
[TBL] [Abstract][Full Text] [Related]
27. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue.
Falkevall A; Mehlem A; Folestad E; Ning FC; Osorio-Conles Ó; Radmann R; de Hollanda A; Wright SD; Scotney P; Nash A; Eriksson U
J Hepatol; 2023 May; 78(5):901-913. PubMed ID: 36717026
[TBL] [Abstract][Full Text] [Related]
29. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
Manne V; Handa P; Kowdley KV
Clin Liver Dis; 2018 Feb; 22(1):23-37. PubMed ID: 29128059
[TBL] [Abstract][Full Text] [Related]
30. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
[TBL] [Abstract][Full Text] [Related]
31. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
[No Abstract] [Full Text] [Related]
32. Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue.
Petrescu M; Vlaicu SI; Ciumărnean L; Milaciu MV; Mărginean C; Florea M; Vesa ȘC; Popa M
Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630058
[TBL] [Abstract][Full Text] [Related]
33. Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD).
Choudhary NS; Duseja A; Kalra N; Das A; Dhiman RK; Chawla YK
Ann Hepatol; 2012; 11(4):478-86. PubMed ID: 22700629
[TBL] [Abstract][Full Text] [Related]
34. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
[TBL] [Abstract][Full Text] [Related]
35. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis.
Lu S; Xie Q; Kuang M; Hu C; Li X; Yang H; Sheng G; Xie G; Zou Y
J Transl Med; 2023 Mar; 21(1):192. PubMed ID: 36915168
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.
Fan M; Choi YJ; Tang Y; Bae SM; Yang HP; Kim EK
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31717842
[TBL] [Abstract][Full Text] [Related]
37. Harnessing Muscle-Liver Crosstalk to Treat Nonalcoholic Steatohepatitis.
Chakravarthy MV; Siddiqui MS; Forsgren MF; Sanyal AJ
Front Endocrinol (Lausanne); 2020; 11():592373. PubMed ID: 33424768
[TBL] [Abstract][Full Text] [Related]
38. The Role of Olfactomedin 2 in the Adipose Tissue-Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease.
Barrientos-Riosalido A; Bertran L; Vilaró-Blay M; Aguilar C; Martínez S; Paris M; Sabench F; Riesco D; Binetti J; Castillo DD; Richart C; Auguet T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982296
[TBL] [Abstract][Full Text] [Related]
39. Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
Kalavalapalli S; Leiva EG; Lomonaco R; Chi X; Shrestha S; Dillard R; Budd J; Romero JP; Li C; Bril F; Samraj G; Pennington J; Townsend P; Orlando F; Shetty S; Mansour L; Silva-Sombra LR; Bedossa P; Malaty J; Barb D; Gurka MJ; Cusi K
J Clin Endocrinol Metab; 2023 Apr; 108(5):1192-1201. PubMed ID: 36378995
[TBL] [Abstract][Full Text] [Related]
40. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]